Market revenue in 2022 | USD 129.8 million |
Market revenue in 2030 | USD 495.1 million |
Growth rate | 18.2% (CAGR from 2022 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Bio-Rad Laboratories Inc, Illumina Inc, Merck KGaA, Becton Dickinson & Co, Standard BioTools Inc, 10x Genomics Inc Ordinary Shares - Class A, BGI Group, Novogene |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single cell analysis market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 54.85% in 2022. Horizon Databook has segmented the Brazil single cell analysis market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
According to Front Line Genomics in May 2023, despite having a relatively young genetics history, Brazil has advanced in the field of genomics more than other South American countries due to its improving infrastructure, expansion of sequencing technologies, and increasing interest of global players in this region.
For instance, according to Genome Web in October 2019, Veritas Intercontinental signed an agreement with Genomika, a genetic testing lab based in Brazil, to offer whole genome and exome sequencing services in this region, which is anticipated to drive the market.
A natural demographic and ethnic diversity in the regional population is also expected to attract R&D for DNA sequencing-related diagnostic kits & therapies for certain diseases in this region. In March 2020, Brazilian scientists conducted the first genetic sequencing of SARS-CoV-2 within 48 hours.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil single cell analysis market , including forecasts for subscribers. This country databook contains high-level insights into Brazil single cell analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account